View More Recent Stories

May 5, 2016 04:05PM Exelixis to Present at the Bank of America Merrill Lynch 2016 Health Care Conference on May 10
May 4, 2016 04:05PM Exelixis Announces First Quarter 2016 Financial Results and Provides Corporate Update
Apr 26, 2016 04:05PM Exelixis to Release First Quarter 2016 Financial Results on Wednesday, May 4, 2016
Apr 25, 2016 01:54PM Exelixis (EXEL) Announces FDA Approval for CABOMETYX to Treat Advanced RCC
Apr 25, 2016 01:52PM Exelixis Announces FDA Approval of CABOMETYX™ (Cabozantinib) Tablets for Patients with Advanced Renal Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy
Apr 25, 2016 01:52PM ADDING MULTIMEDIA Exelixis Announces FDA Approval of CABOMETYX™ (Cabozantinib) Tablets for Patients with Advanced Renal Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy
Jan 6, 2014 09:37AM Pre-Open Stock Movers 1/6: (SCTY) (RDWR) (SIRI) Higher; (SCSS) (HGG) (TWTR) Lower (more...)
View More Recent Stories